 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial |
| Tae Hoon Kim, Na Hye Kim, Jin Dong Kim, Young Nam Kim, Yu Jin Kim, Eun Jung Kim, Ki Deok Yoo, Choong Heon Ryu, Ha Hun Song, Hyun Kim |
|
J Liver Cancer. 2021;21(2):146-154. Published online August 11, 2021 DOI: https://doi.org/10.17998/jlc.2021.05.20 |
|
Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial Journal of Liver Cancer. 2021;21(2):146-154  Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study Journal of Hepatocellular Carcinoma. 2021;Volume 8:1459-1471 Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma BMC Cancer. 2015;15(1): Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study [Retraction] Journal of Hepatocellular Carcinoma. 2022;Volume 9:27-28 A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients Cancer Management and Research. 2021;Volume 13:5373-5382 Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma Cancer Management and Research. 2021;Volume 13:5391-5402 Economic Evaluation of Transarterial Chemoembolization With Lipiodol Versus Drug Eluting Bead for the Treatment of Hepatocellular Carcinoma In Egyptian Patients Value in Health. 2015;18(3):A205-A206 03:54 PM Abstract No. 214 Comparison of treatment response, survival and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres versus conventional transarterial chemoembolization in treating hepatocellular carcinoma Journal of Vascular and Interventional Radiology. 2019;30(3):S96 Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma Journal of Interventional Medicine. 2021;4(1):11-14 Sorafenib Plus Drug-eluting Bead Transarterial Chemoembolization for Early Intrahepatic Stage-progressed Advanced Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization . 2022; |
